Granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Document Type
Document Type
Transaction costs
Payments To Acquire Variable Interest Entities, Transaction Costs
Payments To Acquire Variable Interest Entities, Transaction Costs
Other expense (income), net
Other Nonoperating Income (Expense)
Percent of average of average of volume-weighted average price of Common stock
Payment To Acquire Interest In Affiliate, Equity Interest Issued Or Issuable, Average Price Of Common Stock, Percent
Payment To Acquire Interest In Affiliate, Equity Interest Issued Or Issuable, Average Price Of Common Stock, Percent
Options granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Related Party
Related Party [Axis]
Amortization of convertible debt discount
Amortization of Debt Discount (Premium)
Segments [Axis]
Segments [Axis]
Vested (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Level 3
Fair Value, Inputs, Level 3 [Member]
Option period (in days)
Sale Of Stock, Option, Term
Sale Of Stock, Option, Term
Payments to related party
Related Party Transaction, Expenses from Transactions with Related Party
Over One Year Through Five Years
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Range [Domain]
Statistical Measurement [Domain]
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities and Equity [Abstract]
Line of Credit
Line of Credit [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Debt
Long-term Debt and Finance Lease Obligations, Including Current Maturities
Long-term Debt and Finance Lease Obligations, Including Current Maturities
Deferred income tax liabilities, net
Deferred income tax liabilities, net
Deferred Income Tax Liabilities, Net
Security Exchange Name
Security Exchange Name
Intangible assets, net
Intangible assets, net
Intangible Assets, Net (Excluding Goodwill)
Equipment Financing Obligations
Finance Obligations [Member]
Finance Obligations [Member]
Proceeds from issuance of convertible debt, net of issuance costs
Proceeds from Convertible Debt
Contract with Customer, Asset, Net [Abstract]
Contract with Customer, Asset, after Allowance for Credit Loss [Abstract]
Employee stock purchase plan, discount rate (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date
Remainder of 2021
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal Remainder of Fiscal Year
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal Remainder of Fiscal Year
Loss from operations
Operating Income (Loss)
Pharma contract asset, increase (as a percent)
Contract With Customer, Asset, Percent
Contract With Customer, Asset, Percent
Total current liabilities
Liabilities, Current
Summary of Contract Assets and Liabilities
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
Beginning balance (in dollars per share)
Ending balance (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Total Debt
Finance Lease, Liability, Payment, Due
Issuance of restricted stock, net of forfeitures
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
ASSETS
Assets [Abstract]
Entity Address, State or Province
Entity Address, State or Province
Vested (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Weighted average fair value/share at grant date (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
Cash paid for operating leases
Operating Lease, Payments
Accounts payable
Accounts Payable, Current
2024
Long-Term Debt, Maturity, Year Three
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Operating lease right-of-use assets
Operating Lease, Right-of-Use Asset
Unrealized loss on effective cash flow hedge, net of tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
Unamortized debt discount
Debt Instrument, Unamortized Discount
Amortization Period
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life
Common Stock Offering
Common Stock Offering [Member]
Common Stock Offering
2022
Lessee, Operating Lease, Liability, to be Paid, Year One
Beginning balance (in shares)
Ending balance (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
2022
Finance Lease, Liability, to be Paid, Year One
2025
Lessee, Operating Lease, Liability, to be Paid, Year Four
Total long-term debt, net
Long-term Debt and Lease Obligation
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Beginning balance (in shares)
Ending balance (in shares)
Shares, Outstanding
Diluted (in dollars per share)
Diluted net loss per share (in dollars per share)
Income (Loss) from Continuing Operations, Per Diluted Share
Income Taxes
Income Tax, Policy [Policy Text Block]
Total operating expenses
Operating Expenses
OTHER COMPREHENSIVE LOSS:
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Exercisable at March 31, 2021 (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Other long-term liabilities
Other Liabilities, Noncurrent
Stock-based compensation expense - options and restricted stock
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Less:
Share-based Compensation Arrangement by Share-based Payment Award, Reductions in Options Outstanding [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Reductions in Options Outstanding
Thereafter
Lessee, Operating Lease, Liability, to be Paid, after Year Four
Lessee, Operating Lease, Liability, to be Paid, after Year Four
Inventories
Inventory, Net
Thereafter
Long-Term Debt, Maturity, after Year Five
Measurement Frequency [Domain]
Measurement Frequency [Domain]
Business Acquisition [Axis]
Business Acquisition [Axis]
Amortization of contract commissions
Capitalized Contract Cost, Amortization
Geographical [Domain]
Geographical [Domain]
Over Five Years
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10
Convertible Notes, conversion ratio
Debt Instrument, Convertible, Conversion Ratio
Statement [Line Items]
Statement [Line Items]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Class of Stock
Class of Stock [Domain]
NET LOSS PER SHARE
Earnings Per Share, Basic and Diluted [Abstract]
Measurement Input Type [Domain]
Measurement Input Type [Domain]
Statement [Table]
Statement [Table]
Range [Axis]
Statistical Measurement [Axis]
Convertible Debt Securities
Convertible Debt Securities [Member]
Credit Facility
Credit Facility [Axis]
Thereafter
Finite-Lived Intangible Asset, Expected Amortization, After Year Four
Finite-Lived Intangible Asset, Expected Amortization, After Year Four
Estimated fair value of debt
Debt Instrument, Fair Value Disclosure
Ownership of convertible notes (as a percent)
Debt Instrument, Covenant, Threshold of Default, Percent Of Owners Of Debt
Debt Instrument, Covenant, Threshold of Default, Percent Of Owners Of Debt
Repayment of equipment financing obligations
Repayments of Equipment and Other Finance Obligation
Repayments of Equipment and Other Finance Obligation
Convertible senior notes, net
Convertible Debt, Noncurrent
Consideration paid to other shareholders
Payments to Acquire Additional Interest in Subsidiaries
Foreign Tax Authority
Foreign Tax Authority [Member]
Entity Small Business
Entity Small Business
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares sold in offering (in shares)
Sale of Stock, Number of Shares Issued in Transaction
Debt
Debt Disclosure [Text Block]
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV [Domain]
Prepaid assets
Prepaid Expense, Current
Issuance of common stock, net
Proceeds from Issuance of Common Stock
Total cost of revenue
Cost of Revenue
Debt Instrument, Redemption, Period One
Debt Instrument, Redemption, Period One [Member]
Proceeds from sales and maturities of marketable securities
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale
Amendment Flag
Amendment Flag
Schedule of Earnings Per Share, Basic and Diluted
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Summary of Restricted Stock Activity
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Finite-Lived Intangible Assets, Major Class Name
Finite-Lived Intangible Assets, Major Class Name [Domain]
Fair Value, Assets Measured on Recurring Basis
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Net cash provided by (used in) operating activities
Net Cash Provided by (Used in) Operating Activities
Accounts payable, accrued and other liabilities
Increase (Decrease) in Accounts Payable and Other Operating Liabilities
Entity Central Index Key
Entity Central Index Key
Dilutive effect of Convertible Notes (in shares)
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
Related Party
Related Party [Domain]
Measurement Frequency [Axis]
Measurement Frequency [Axis]
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Marketable securities, at fair value
Fair Value
Total
Debt Securities, Available-for-sale, Current
Financial Instruments [Domain]
Financial Instruments [Domain]
Finite-Lived Intangible Assets by Major Class
Finite-Lived Intangible Assets by Major Class [Axis]
Property and equipment included in accounts payable
Capital Expenditures Incurred but Not yet Paid
Geographical [Axis]
Geographical [Axis]
Subsequent Events
Subsequent Events [Text Block]
Segments [Domain]
Segments [Domain]
Unrecognized stock-based compensation cost
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Interest income from loan receivable
Interest and Fee Income, Loans and Leases
Gross Unrealized Gains
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
Statement of Cash Flows [Abstract]
2025
Long-Term Debt, Maturity, Year Four
Property, Plant and Equipment, Type
Long-Lived Tangible Asset [Axis]
Employee Stock Purchase Plan
Employee Stock [Member]
Measurement Input, Expected Dividend Rate
Measurement Input, Expected Dividend Rate [Member]
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Minimum lease payments for leases executed but not yet commenced
Lessee, Operating Lease, Lease not Yet Commenced, Amount
Lessee, Operating Lease, Lease not Yet Commenced, Amount
2023
Lessee, Operating Lease, Liability, to be Paid, Year Two
Amortization of intangibles
Amortization of intangibles
Amortization of Intangible Assets
Line of Credit Facility [Table]
Line of Credit Facility [Table]
Supplemental Operating Lease Information
Lease, Cost [Table Text Block]
2024
Lessee, Operating Lease, Liability, to be Paid, Year Three
Other assets
Other Assets, Noncurrent
Investment in Non-Consolidated Affiliate
Equity Method Investments and Joint Ventures Disclosure [Text Block]
Conversion price on applicable trading day (as a percent)
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger
Segment Information
Segment Reporting Disclosure [Text Block]
Issuance of common stock - public offering, net of underwriting discounts
Stock Issued During Period, Value, New Issues
Cash equivalents
Cash and Cash Equivalents, Fair Value Disclosure
Issuance of restricted stock, net of forfeitures (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Total assets
Carrying amount of investment in non-consolidated affiliate
Assets
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Loan receivable from non-consolidated affiliate
Due from Related Parties, Noncurrent
Write-off of COVID-19 PCR testing inventory and equipment
PCR testing, amount recorded, COVID-19
Polymerase Chain Reaction Testing, Exit Costs, COVID-19
Polymerase Chain Reaction Testing, Exit Costs, COVID-19
Beginning balance (in shares)
Ending balance (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Title of 12(b) Security
Title of 12(b) Security
Interest expense, accretion of debt discount
Interest Expense, Debt, Accretion Of Debt Discount
Interest Expense, Debt, Accretion Of Debt Discount
Total Debt
Long-term Debt and Lease Obligation [Abstract]
Finite-lived intangibles, net
Total
Finite-Lived Intangible Assets, Net
Subsequent Event Type [Axis]
Subsequent Event Type [Axis]
Net unrealized loss on marketable securities, net of tax
Net unrealized loss on marketable securities, net of tax
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Contract with Customer, Liability [Abstract]
Contract with Customer, Liability [Abstract]
Long-term Debt, by Current and Noncurrent [Abstract]
Long-term Debt, by Current and Noncurrent [Abstract]
Interest expense, net
Interest Expense
Net proceeds of common stock
Sale of Stock, Consideration Received on Transaction
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Accrued interest receivable
Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss
Unrealized loss on investment in non-consolidated affiliate
Unrealized loss on investment in non-consolidated affiliate
Equity Securities, FV-NI, Unrealized Gain (Loss)
Product and Service [Axis]
Product and Service [Axis]
Total liabilities
Liabilities
Investment Type [Axis]
Investment Type [Axis]
Interest expense, amortization of debt issuance costs
Interest Expense, Debt, Amortization Of Debt Issuance Costs
Interest Expense, Debt, Amortization Of Debt Issuance Costs
Unrecognized share-based compensation expense, weighted-average recognition period (in years)
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Expected volatility (%)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Equipment financing obligations
Other Long-term Debt
Less: imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
2023
Long-Term Debt, Maturity, Year Two
Schedule of Related Party Transactions, by Related Party [Table]
Schedule of Related Party Transactions, by Related Party [Table]
Pharma contract liability, revenue recognized
Contract with Customer, Liability, Revenue Recognized
Net loss
Net Income (Loss) Available to Common Stockholders, Basic
Level 1
Fair Value, Inputs, Level 1 [Member]
Non-cash operating lease expense
Operating Lease, Expense
Inventories
Increase (Decrease) in Inventories
Debt instrument, weighted average interest rates
Debt, Weighted Average Interest Rate
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Recurring and Nonrecurring [Table]
Number of shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Debt Instrument [Axis]
Debt Instrument [Axis]
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Other non-cash items
Other Operating Activities, Cash Flow Statement
Adjustments to reconcile net income to net cash provided by operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Basic (in dollars per share)
Basic net loss per share (in dollars per share)
Income (Loss) from Continuing Operations, Per Basic Share
Revenue from Contract with Customer [Abstract]
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Research and development
Research and Development Expense
Public offering price (in dollars per share)
Sale of Stock, Price Per Share, Public Offering Price
Sale of Stock, Price Per Share, Public Offering Price
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity, Not Primary Beneficiary [Member]
Subsequent Event
Subsequent Event [Member]
Weighted average exercise price, beginning balance (in dollars per share)
Weighted average exercise price, ending balance (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Accounting Changes and Error Corrections [Abstract]
Business acquisition
Payments to Acquire Businesses, Net of Cash Acquired
Common stock, shares authorized
Common Stock, Shares Authorized
Less: Current portion of long-term debt
Long-term Debt and Lease Obligation, Current
Summary of Segment Information
Schedule of Segment Reporting Information, by Segment [Table Text Block]
PCR testing, write-offs, COVID-19
Polymerase Chain Reaction Testing, Write-Offs, COVID-19
Polymerase Chain Reaction Testing, Write-Offs, COVID-19
Income Statement [Abstract]
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent [Member]
Investments Classified by Contractual Maturity Date
Investments Classified by Contractual Maturity Date [Table Text Block]
Operating lease liabilities
Operating Lease, Liability, Noncurrent
2025
Finite-Lived Intangible Asset, Expected Amortization, Year Four
Prepaid and other assets
Increase (Decrease) in Prepaid Expense and Other Assets
Over-Allotment Option
Over-Allotment Option [Member]
Schedule of Segment Reporting Information, by Segment [Table]
Schedule of Segment Reporting Information, by Segment [Table]
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Current assets
Assets, Current [Abstract]
Interest expense, contractual coupon interest
Interest Expense, Debt, Contractual Coupon Interest
Interest Expense, Debt, Contractual Coupon Interest
Income Tax Authority [Domain]
Income Tax Authority [Domain]
CASH FLOWS FROM INVESTING ACTIVITIES
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]
Consolidated Entities [Axis]
Consolidated Entities [Axis]
COMPREHENSIVE LOSS
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
2024
Finance Lease, Liability, to be Paid, Year Three
Dividend yield (%)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
2022
Long-Term Debt, Maturity, Year One
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment
City Area Code
City Area Code
Income Tax Authority [Axis]
Income Tax Authority [Axis]
Document Period End Date
Document Period End Date
Goodwill and Intangible Assets
Goodwill and Intangible Assets Disclosure [Text Block]
0.25% Convertible Senior Notes due 2028
Zero Point Two Five Percent Convertible Senior Notes [Member]
Zero Point Two Five Percent Convertible Senior Notes
Summary of Disaggregation of Revenue
Disaggregation of Revenue [Table Text Block]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis
Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]
Long-term Debt, Type [Domain]
Long-term Debt, Type [Domain]
Non-cash stock-based compensation
Share-based Payment Arrangement, Noncash Expense
Remainder of 2021
Long-Term Debt, Maturity, Remainder of Fiscal Year
Cover page.
Cover [Abstract]
Less:
Share-based Compensation Arrangement by Share-based Payment Award, Reduction in Options Outstanding, Weighted Average Exercise Price [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Reduction in Options Outstanding, Weighted Average Exercise Price
Measurement Input Type [Axis]
Measurement Input Type [Axis]
Convertible debt, if converted, value in excess of principal
Debt Instrument, Convertible, If-converted Value in Excess of Principal
Thereafter
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal After Year Five
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal After Year Five
Long-term debt
Long-term Debt
Inivata Limited
Affiliated Entity [Member]
Lessee, Lease, Description [Line Items]
Lessee, Lease, Description [Line Items]
Leases
Lessee, Operating Leases [Text Block]
Fair Value Disclosures [Abstract]
Total debt
Debt and Lease Obligation
Customer Relationships
Customer Relationships [Member]
COST OF REVENUE
Cost of Goods and Services Sold
Unrealized loss on effective cash flow hedge, net of tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax
Equity Components [Axis]
Equity Components [Axis]
Commercial Insurance
Commercial Insurance [Member]
Commercial Insurance [Member]
Restricted Stock
Restricted Stock [Member]
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
Minimum
Minimum [Member]
Prepaid lease asset
Prepaid Rent, Noncurrent
Prepaid Rent, Noncurrent
Consolidated Entities [Domain]
Consolidated Entities [Domain]
Current portion of operating lease liabilities
Less: current portion
Operating Lease, Liability, Current
Purchase option, measurement input (as a percent)
Purchase Option, Measurement Input
Purchase Option, Measurement Input
Equity Method Investments and Joint Ventures [Abstract]
Forfeited (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Asset-backed securities
Asset-backed Securities [Member]
Long-term pharma contract assets
Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent
Entity Interactive Data Current
Entity Interactive Data Current
Corporate bonds
Corporate Bond Securities [Member]
Weighted average exercise price, exercised (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Fair Value Measurements
Fair Value Disclosures [Text Block]
Equity Transactions
Stockholders' Equity Note Disclosure [Text Block]
Summary of Stock Option Activity
Share-based Payment Arrangement, Option, Activity [Table Text Block]
Loan with imputed interest, discount
Receivable with Imputed Interest, Discount
Remainder of 2021
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Stock-Based Compensation
Share-based Payment Arrangement [Policy Text Block]
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional paid-in capital
Additional Paid in Capital, Common Stock
Entity Registrant Name
Entity Registrant Name
Subsequent Event Type [Domain]
Subsequent Event Type [Domain]
Statement of Stockholders' Equity [Abstract]
Weighted-average discount rate
Operating Lease, Weighted Average Discount Rate, Percent
Total non-current assets
Assets, Noncurrent
Unamortized debt issuance costs
Debt Issuance Costs, Net
Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Total cost of intangibles
Intangible Assets, Gross (Excluding Goodwill)
COVID-19, deferred social security payroll tax
Social Security Tax, Employer, Deferral, CARES Act
Social Security Tax, Employer, Deferral, CARES Act
Clinical Services
Clinical Services [Member]
Clinical Services [Member]
Premiums paid for capped call confirmations
Payments Of Premiums For Capped Call Confirmations
Payments Of Premiums For Capped Call Confirmations
Schedule of Equity Method Investments [Table]
Schedule of Equity Method Investments [Table]
Basic weighted average shares outstanding (in shares)
Weighted Average Number of Shares Issued, Basic
Total Debt
Long Term Debt Including Current Maturities Due
Long term debt including current maturities due.
2024
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal in Year Three
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal in Year Three
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Accounts receivable, net
Accounts Receivable, after Allowance for Credit Loss, Current
Total remaining lease payments
Lessee, Operating Lease, Liability, to be Paid
Threshold trading days
Debt Instrument, Convertible, Threshold Trading Days
Self-Pay
Self Pay Services [Member]
Self Pay Services [Member]
Debt Instrument, Redemption, Period [Domain]
Debt Instrument, Redemption, Period [Domain]
Restricted cash
Restricted Cash, Noncurrent
Gross Unrealized Losses
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax
Sale of Stock [Axis]
Sale of Stock [Axis]
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Debt Instrument, Redemption, Period Two
Debt Instrument, Redemption, Period Two [Member]
Realized gains (losses) on marketable securities
Debt Securities, Available-for-sale, Realized Gain (Loss)
Goodwill
Goodwill
One Year or Less
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Total other comprehensive loss, net of tax
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Document Transition Report
Document Transition Report
Debt Instrument, Redemption, Period [Axis]
Debt Instrument, Redemption, Period [Axis]
Summary of Fair Value of Each Stock Option Award Granted
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
1.25% Convertible Senior Notes due 2025
One Point Two Five Percent Convertible Senior Notes [Member]
One Point Two Five Percent Convertible Senior Notes
Total pharma capitalized commissions
Capitalized Contract Cost, Gross
Debt instrument, face amount
Debt Instrument, Face Amount
Level 2
Fair Value, Inputs, Level 2 [Member]
Other current assets
Other Assets, Current
Document Quarterly Report
Document Quarterly Report
Employee Retention Tax Credit, COVID-19
Employee Retention Tax Credit, CARES Act
Employee Retention Tax Credit, CARES Act
Options canceled or expired (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Equity [Abstract]
Total
Assets, Fair Value Disclosure
Stock issuance fees and expenses
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Supplemental disclosure of non-cash investing and financing information:
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Classes of Intangible Assets
Schedule of Intangible Assets and Goodwill [Table Text Block]
Pharma contract liabilities
Current pharma contract liabilities
Contract with Customer, Liability, Current
Subsequent Event [Line Items]
Subsequent Event [Line Items]
Accounting Standards Update [Extensible List]
Accounting Standards Update [Extensible List]
Weighted average exercise price, granted (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Cumulative Effect, Period of Adoption [Axis]
Cumulative Effect, Period of Adoption [Axis]
Credit Facility
Credit Facility [Domain]
Summary of Significant Accounting Policies
Accounting Standards Update and Change in Accounting Principle [Text Block]
Convertible Notes, conversion price (in dollars per share)
Debt Instrument, Convertible, Conversion Price
Estimated Amortization Expense
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Florida
FLORIDA
Diluted (in shares)
Diluted weighted average shares outstanding (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Number of operating segments
Number of Operating Segments
Expected term (in years)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term
Entity File Number
Entity File Number
Forfeited (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Debt Disclosure [Abstract]
Weighted-average remaining lease term (in years)
Operating Lease, Weighted Average Remaining Lease Term
Sales and marketing
Selling and Marketing Expense
Preference Shares
Preference Shares [Member]
Preference Shares
CASH FLOWS FROM OPERATING ACTIVITIES
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Common stock, $0.001 par value, (250,000,000 shares authorized; 117,136,654 and 112,075,474 shares issued and outstanding, respectively)
Common Stock, Value, Outstanding
Net cash provided by financing activities
Net Cash Provided by (Used in) Financing Activities
Finance Obligations
Capital Lease Obligations [Abstract]
ESPP expense
APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition
Capped Call Transactions
Capped Call Transactions [Member]
Capped Call Transactions
Stock compensation expense (gain)
Share-based Payment Arrangement, Expense
2022
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal in Year One
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal in Year One
Medicare and Medicaid
Medicare And Other Governmental [Member]
Medicare And Other Governmental [Member]
Common stock issuance ESPP Plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Total revenue
Revenue from Contract with Customer, Including Assessed Tax
Long-term pharma capitalized commissions
Capitalized Contract Cost, Net, Noncurrent
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets [Line Items]
Document Fiscal Year Focus
Document Fiscal Year Focus
2023
Finite-Lived Intangible Asset, Expected Amortization, Year Two
2025
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal in Year Four
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal in Year Four
Commercial paper
Commercial Paper [Member]
Less: Current portion of long-term debt
Long-term Debt, Current Maturities
Entity Current Reporting Status
Entity Current Reporting Status
Offering price per share (in dollars per share)
Sale of Stock, Price Per Share
2025
Finance Lease, Liability, to be Paid, Year Four
Effective interest rate on Convertible Notes (as a percent)
Debt Instrument, Interest Rate During Period
Measurement Input, Price Volatility
Measurement Input, Price Volatility [Member]
Related Party Transaction [Axis]
Related Party Transaction [Axis]
Subsequent Event [Table]
Subsequent Event [Table]
Purchases of marketable securities
Payments to Acquire Debt Securities, Available-for-sale
Schedule of Long-term Debt Instruments [Table]
Schedule of Long-term Debt Instruments [Table]
Increase in Pharma contract assets
Increase (Decrease) in Contract with Customer, Asset
Granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Common stock, shares issued
Common Stock, Shares, Issued
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Measurement Input, Risk Free Interest Rate
Measurement Input, Risk Free Interest Rate [Member]
Total operating lease liabilities
Operating Lease, Liability
Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]
Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]
Long-term debt, net
Long-term Debt, Excluding Current Maturities
Segment Reporting [Abstract]
Accounts receivable, net
Increase (Decrease) in Accounts Receivable
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Statement of Comprehensive Income [Abstract]
Total stockholders’ equity
Beginning balance
Ending balance
Accumulated deficit
Accumulated deficit
Stockholders' Equity Attributable to Parent
Payments of equity issue costs
Payments of Stock Issuance Costs
Purchase price
Business Combination, Consideration Transferred
Total liabilities and stockholders' equity
Liabilities and Equity
Accumulated other comprehensive (loss) income
Accumulated Other Comprehensive Income (Loss), Net of Tax
Total long-term liabilities
Liabilities, Noncurrent
Entity Address, City or Town
Entity Address, City or Town
Accrued compensation
Employee-related Liabilities, Current
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Axis]
Operating lease costs
Operating Lease, Cost
General and administrative
General and Administrative Expense
Financial Instrument [Axis]
Financial Instrument [Axis]
Antidilutive securities (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Line of Credit Facility [Line Items]
Line of Credit Facility [Line Items]
Pharma Services
Pharma Services [Member]
Pharma Services [Member]
Indefinite-lived Intangible Assets [Axis]
Indefinite-lived Intangible Assets [Axis]
Equity Component [Domain]
Equity Component [Domain]
Premiums paid for capped call confirmations
Adjustments to Additional Paid in Capital, Decrease From Purchase Of Calls Related To Convertible Debt
Adjustments to Additional Paid in Capital, Decrease From Purchase Of Calls Related To Convertible Debt
Imputed interest rate (as a percent)
Line of Credit Facility, Interest Rate at Period End
Deferred tax assets, valuation allowance
Deferred Tax Assets, Valuation Allowance
Total gross profit
Gross Profit
Property and equipment (net of accumulated depreciation of $98,746 and $92,895, respectively)
Property, Plant and Equipment, Net
2024
Finite-Lived Intangible Asset, Expected Amortization, Year Three
Entity Tax Identification Number
Entity Tax Identification Number
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Table]
Stock-Based Compensation
Share-based Payment Arrangement [Text Block]
Net loss
NET LOSS
Net loss
Net Income (Loss) Attributable to Parent
Long-term debt, net
Finance Lease, Liability, Noncurrent
Changes in assets and liabilities, net
Increase (Decrease) in Operating Capital [Abstract]
Client direct billing
Client Direct Billing [Member]
Client Direct Billing [Member]
PCR testing, general and administrative expenses, COVID-19
Polymerase Chain Reaction Testing, General and Administrative Expenses, COVID-19
Polymerase Chain Reaction Testing, General and Administrative Expenses, COVID-19
Remainder of 2021
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
2023
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal in Year Two
Long-term Debt and Finance Lease Obligations, Maturities, Repayments of Principal in Year Two
Trade Name - Indefinite lived
Trade Names [Member]
Leases [Abstract]
Long-term Debt, Type [Axis]
Long-term Debt, Type [Axis]
Total current assets
Assets, Current
Current Fiscal Year End Date
Current Fiscal Year End Date
Operating expenses:
Operating Expenses [Abstract]
Earnings Per Share [Abstract]
Prepaid lease asset
Increase (Decrease) in Prepaid Construction
Increase (Decrease) in Prepaid Construction
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Additional investment in non-consolidated affiliate
Equity Securities without Readily Determinable Fair Value, Additional Investment
Equity Securities without Readily Determinable Fair Value, Additional Investment
Number of shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Stockholders’ equity
Stockholders' Equity Attributable to Parent [Abstract]
Document Fiscal Period Focus (i.e. Q1,Q2,Q3,FY)
Document Fiscal Period Focus
Subsidiary, Sale of Stock [Line Items]
Subsidiary, Sale of Stock [Line Items]
Interest receivable on loan receivable from non-consolidated affiliate
Receivable With Imputed Interest, Non-Consolidated Affiliates
Receivable With Imputed Interest, Non-Consolidated Affiliates
Thereafter
Finance Lease, Liability, to be Paid, after Year Five
Long-term pharma contract liabilities
Contract with Customer, Liability, Noncurrent
Supplemental disclosure of cash flow information:
Supplemental Cash Flow Information [Abstract]
Discount on shares
Common Stock, Discount on Shares
Business Acquisition, Acquiree [Domain]
Business Acquisition, Acquiree [Domain]
Redemption price of principal (as a percent)
Debt Instrument, Redemption Price, Percentage
Common stock issuance ESPP Plan (in shares)
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Entity Filer Category
Entity Filer Category
Common Stock
Common Stock [Member]
Product and Service [Domain]
Product and Service [Domain]
Property, Plant and Equipment, Type
Long-Lived Tangible Asset [Domain]
Current pharma capitalized commissions
Capitalized Contract Cost, Net, Current
Convertible Debt
Convertible Debt [Member]
Net unrealized loss for remeasurement of investment
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
Present value of loan receivable with imputed interest
Receivable with Imputed Interest, Net Amount
U.S. Treasury securities
US Treasury Securities [Member]
Issuance of common stock - public offering, net of underwriting discounts (in shares)
Stock Issued During Period, Shares, New Issues
Leasehold Improvements
Leasehold Improvements [Member]
Cost
Finite-Lived Intangible Assets, Gross
Schedule of Equity Method Investments [Line Items]
Schedule of Equity Method Investments [Line Items]
Stated interest rate (as a percent)
Debt Instrument, Interest Rate, Stated Percentage
Money market funds
Money Market Funds [Member]
Property and equipment, accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Current pharma contract assets
Contract with Customer, Asset, after Allowance for Credit Loss, Current
Issuance of common stock for stock options (in shares)
Options exercised (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Related Party Transactions [Abstract]
Net change in cash, cash equivalents and restricted cash
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Schedule of Future Minimum Lease Payments under Topic 842
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Stock options
Share-based Payment Arrangement, Option [Member]
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Amortized Cost
Debt Securities, Available-for-sale, Amortized Cost, Current
Basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Risk-free interest rate (%)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Subsequent Events [Abstract]
Weighted average exercise price, canceled or expired (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Sale of Stock [Domain]
Sale of Stock [Domain]
Interest rate per annum (as a percent)
Line of Credit Facility, Interest Rate During Period
Revenue Recognition
Revenue from Contract with Customer [Text Block]
Interest paid
Interest Paid, Excluding Capitalized Interest, Operating Activities
Investment in non-consolidated affiliate
Equity Securities without Readily Determinable Fair Value, Amount
Strategic Alliance With Inivata Limited
Strategic Alliance With Inivata Limited [Member]
Strategic Alliance With Inivata Limited
Right-of-use assets obtained in exchange for operating lease liabilities
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Nature of the Business
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Proceeds from equity offering, net of issuance costs
Proceeds From Equity Offering, Net
Proceeds From Equity Offering, Net
Remainder of 2021
Finance Lease, Liability, to be Paid, Remainder of Fiscal Year
2022
Finite-Lived Intangible Asset, Expected Amortization, Year One
Class of Stock
Class of Stock [Axis]
Loan receivable from non-consolidated affiliate
Payments to Fund Long-term Loans to Related Parties
Principal amount priced to investors (as a percent)
Debt Instrument, Convertible Notes, Aggregate Principle Amount Rate
Debt Instrument, Convertible Notes, Aggregate Principle Amount Rate
Income tax expense
Income Tax Expense (Benefit)
Income taxes (refunded) paid, net
Income Taxes Paid, Net
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Summary of Maturities of Long-Term Debt
Schedule of Maturities of Long-term Debt [Table Text Block]
Accounting Standards Update and Change in Accounting Principle [Table]
Accounting Standards Update and Change in Accounting Principle [Table]
Indefinite-lived Intangible Assets, Major Class Name [Domain]
Indefinite-lived Intangible Assets, Major Class Name [Domain]
Current portion of equipment financing obligations
Less: Current portion of financing obligations
Less: Current portion of long-term debt
Finance Lease, Liability, Current
Local Phone Number
Local Phone Number
Payment for business acquisition
Payments to Acquire Businesses, Gross
Premium on offering price (as a percent)
Sale of Stock, Premium On Offering Price
Sale of Stock, Premium On Offering Price
Capped Call Transactions, Number Of Underlying Shares
Capped Call Transactions, Number Of Underlying Shares
Capped Call Transactions, Number Of Underlying Shares
Cumulative Effect, Period of Adoption [Domain]
Cumulative Effect, Period of Adoption [Domain]
Accrued expenses and other liabilities
Accrued Liabilities and Other Liabilities
Common stock issued for consideration
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
Trapelo Health
Trapelo Health [Member]
Trapelo Health
Principal
Long-term Debt, Gross
Summary of Long Term Debt
Schedule of Long-term Debt Instruments [Table Text Block]
Depreciation
Depreciation
Entity Address, Address Line One
Entity Address, Address Line One
Purchase Option
Purchase Option [Member]
Purchase Option
Entity Address, Address Line Two
Entity Address, Address Line Two
Total pharma contract liabilities
Contract with Customer, Liability
Related Party Transaction [Domain]
Related Party Transaction [Domain]
Entity Emerging Growth Company
Entity Emerging Growth Company
Issuance of common stock for stock options
Stock Issued During Period, Value, Stock Options Exercised
Trade Name - Indefinite lived
Indefinite-lived Intangible Assets (Excluding Goodwill)
Consecutive trading days
Debt Instrument, Convertible, Threshold Consecutive Trading Days
Schedule of Finite-Lived Intangible Assets [Table]
Schedule of Finite-Lived Intangible Assets [Table]
Capitalized Contract Cost [Abstract]
Capitalized Contract Cost [Abstract]
Line of credit facility maximum borrowing capacity
Line of Credit Facility, Maximum Borrowing Capacity
Award Type
Award Type [Axis]
Award Type [Axis]
Weighted average price
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Repayment of term loan
Repayments of Secured Debt
Maximum
Maximum [Member]
Amortization of debt issue costs
Amortization of Debt Issuance Costs
Accumulated Deficit
Retained Earnings [Member]
Investment in minority interest
Noncontrolling Interest in Variable Interest Entity
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Net cash used in investing activities
Net Cash Provided by (Used in) Investing Activities
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Equity Award
Equity Award [Domain]
Award Type [Domain]
Investments [Domain]
Investments [Domain]
Long-term liabilities
Liabilities, Noncurrent [Abstract]
Trading Symbol
Trading Symbol
Weighted average exercise price, exercisable, ending balance (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Revenue, Initial Application Period Cumulative Effect Transition [Table]
Revenue, Initial Application Period Cumulative Effect Transition [Table]
Private Placement
Private Placement [Member]
Total pharma contract assets
Contract with Customer, Asset, after Allowance for Credit Loss
Discount on principal amount (as a percent)
Discounted Price of Aggregate Principle Rate
Discounted Price of Aggregate Principle Rate
Net Loss Per Share
Earnings Per Share [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Current liabilities
Liabilities, Current [Abstract]
CASH FLOWS FROM FINANCING ACTIVITIES
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]
Entity Shell Company
Entity Shell Company
Segment Reporting Information [Line Items]
Segment Reporting Information [Line Items]
Fair Value, Recurring
Fair Value, Recurring [Member]
2023
Finance Lease, Liability, to be Paid, Year Two
Recently Adopted Accounting Guidance and Accounting Pronouncements Pending Adoption
New Accounting Pronouncements, Policy [Policy Text Block]
Statement of Financial Position [Abstract]